Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

Dickinson, Louise;Ahmed, Hashim U.;Allen, Clare;Barentsz, Jelle O.;Emberton, Mark;et.al.
(2011) European Urology — Vol. 59, n° 4, p. 477-494 (2011)

Files

Dickinson-2011-Magneticresonanceimaging.pdf
  • Restricted Access
  • Adobe PDF
  • 560.31 KB
Request a copy

Details

Authors
  • Dickinson, Louise
    Author
  • Ahmed, Hashim U.
    Author
  • Allen, Clare
    Author
  • Barentsz, Jelle O.
    Author
  • Tombal, Bertrandorcid-logoUCLouvain
    Author
  • Emberton, Mark
    Author
Show more
Abstract
Multiparametric magnetic resonance imaging (mpMRI) may have a role in detecting clinically significant prostate cancer in men with raised serum prostate-specific antigen levels. Variations in technique and the interpretation of images have contributed to inconsistency in its reported performance characteristics.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Dickinson, L., Ahmed, H. U., Allen, C., Barentsz, J. O., Carey, B., Futterer, J. J., Heijmink, S. W., Hoskin, P. J., Kirkham, A., Padhani, A. R., Persad, R., Puech, P., Punwani, S., Sohaib, A. S., Tombal, B., Villers, A., van der Meulen, J., & Emberton, M. (2011). Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. European Urology, 59(4), 477-494. https://doi.org/10.1016/j.eururo.2010.12.009 (Original work published 2011)